Fertility-Sparing Therapy in Young Women With Endometrial Cancer 2010 Update


Erkanli S., Ayhan A.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol.20, no.7, pp.1170-1187, 2010 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 20 Issue: 7
  • Publication Date: 2010
  • Doi Number: 10.1111/igc.0b013e3181e94f5a
  • Journal Name: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
  • Journal Indexes: Science Citation Index Expanded
  • Page Numbers: pp.1170-1187
  • Keywords: Fertility-sparing therapy, Endometrial cancer, Young women, Progesterone therapy, Endometrial carcinoma, IN-VITRO FERTILIZATION, MEDROXYPROGESTERONE ACETATE THERAPY, INTRACYTOPLASMIC SPERM INJECTION, CARCINOMA STAGE-I, CONSERVATIVE MANAGEMENT, SUCCESSFUL PREGNANCY, PRESERVING TREATMENT, MYOMETRIAL INVASION, RISK-FACTORS, ATYPICAL HYPERPLASIA

Abstract

Endometrial cancer (EC) in young and especially null gravid women is a challenging problem with increasing frequency due to both detailed investigations for infertile couples seeking treatment in in vitro fertilization centers and women delaying their plans for pregnancy. Considering very low number of such cases in the literature, fertility-sparing therapy for EC in young women is not standard, although it is widely used. In this review we searched the relevant literature, reviewed selection criteria, therapeutic options, response rates to therapy, special challenges, reproductive outcomes, and follow-up strategies for young women diagnosed with EC.